Source: Translational Psychiatry. Unidades: EACH, FM, FCF
Subjects: MICROBIOLOGIA, FÁRMACOS (SISTEMA NERVOSO CENTRAL), TRANSTORNOS PSICOFISIOLÓGICOS, TRANSTORNOS NEUROPSICOLÓGICOS, MEDICAMENTO
ABNT
DIAS, Thomaz Lüscher et al. Drug repositioning for psychiatric and neurological disorders through a network medicine approach. Translational Psychiatry, v. 10, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1038/s41398-020-0827-5. Acesso em: 04 ago. 2024.APA
Dias, T. L., Schuch, V., Beltrão-Braga, P., Souza, D. M. de, Brentani, H. P., Franco, G. R., & Nakaya, H. T. I. (2020). Drug repositioning for psychiatric and neurological disorders through a network medicine approach. Translational Psychiatry, 10, 10 . doi:10.1038/s41398-020-0827-5NLM
Dias TL, Schuch V, Beltrão-Braga P, Souza DM de, Brentani HP, Franco GR, Nakaya HTI. Drug repositioning for psychiatric and neurological disorders through a network medicine approach [Internet]. Translational Psychiatry. 2020 ; 10 10 .[citado 2024 ago. 04 ] Available from: https://doi.org/10.1038/s41398-020-0827-5Vancouver
Dias TL, Schuch V, Beltrão-Braga P, Souza DM de, Brentani HP, Franco GR, Nakaya HTI. Drug repositioning for psychiatric and neurological disorders through a network medicine approach [Internet]. Translational Psychiatry. 2020 ; 10 10 .[citado 2024 ago. 04 ] Available from: https://doi.org/10.1038/s41398-020-0827-5